| 000 | 01777 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513120108.0 | ||
| 264 | 0 | _c19970522 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199705223362103 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobson, J M | |
| 245 | 0 | 0 |
_aThalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cMay 1997 |
||
| 300 |
_a1487-93 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xcomplications |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xblood |
| 650 | 0 | 4 |
_aStomatitis, Aphthous _xdrug therapy |
| 650 | 0 | 4 |
_aThalidomide _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
| 700 | 1 | _aGreenspan, J S | |
| 700 | 1 | _aSpritzler, J | |
| 700 | 1 | _aKetter, N | |
| 700 | 1 | _aFahey, J L | |
| 700 | 1 | _aJackson, J B | |
| 700 | 1 | _aFox, L | |
| 700 | 1 | _aChernoff, M | |
| 700 | 1 | _aWu, A W | |
| 700 | 1 | _aMacPhail, L A | |
| 700 | 1 | _aVasquez, G J | |
| 700 | 1 | _aWohl, D A | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 336 _gno. 21 _gp. 1487-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199705223362103 _zAvailable from publisher's website |
| 999 |
_c9136059 _d9136059 |
||